Monoclonal immunoglobulin (MIg) related kidney disease with various patterns of damage can present as a renal manifestation of B-cell malignancies and of the non-malignant monoclonal gammopathies, the latter merged under the umbrella of monoclonal gammopathy of renal significance (MGRS). We aimed to compare clinical presentation and pathology patterns of MIg-related kidney damage in B-cell malignancies and in the MGRS setting.
No takes yet. Share an insight, caveat, or question.
Zakharova et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: